Cite
HARVARD Citation
Rodríguez‐Tajes, S. et al. (2021). Low risk of hepatitis B reactivation in patients with severe COVID‐19 who receive immunosuppressive therapy. Journal of viral hepatitis. 28 (1), pp. 89-94. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Rodríguez‐Tajes, S. et al. (2021). Low risk of hepatitis B reactivation in patients with severe COVID‐19 who receive immunosuppressive therapy. Journal of viral hepatitis. 28 (1), pp. 89-94. [Online].